Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Adolor Corporation

Adolor Corporation Reports Year-End 2008 Financial Results

Net product sales of ENTEREG® (alvimopan) recognized for the quarter and year ended December 31, 2008 were approximately $1.1 million and $1.2 million, respectively. Under Adolor’s current revenue recognition policy, revenue related to a customer shipment is deferred until subsequent re-orders by that customer. For the year ended December 31, 2008, net product sales were recognized based on re-orders from approximately 185 hospitals. Total net shipments for the quarter and year ended December 31, 2008 were approximately $1.6 million and $2.2 million,...

• View Other Issues of Health Business Week
  
• View Other NewsRx Publications